{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:01:27Z","timestamp":1792609287588,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI089674"],"award-info":[{"award-number":["U19AI089674"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1106427"],"award-info":[{"award-number":["OPP1106427"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1134076"],"award-info":[{"award-number":["OPP1134076"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["1032350"],"award-info":[{"award-number":["1032350"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1094816"],"award-info":[{"award-number":["OPP1094816"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["DP2LM013102"],"award-info":[{"award-number":["DP2LM013102"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004712","name":"Interface","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004712","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.11.020","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T21:10:26Z","timestamp":1574975426000},"page":"979-992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications"],"prefix":"10.1016","volume":"38","author":[{"given":"F.T.","family":"Cutts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dansereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9148-8448","authenticated-orcid":false,"given":"K.A.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.E.","family":"Metcalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Tatem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0538-0607","authenticated-orcid":false,"given":"S.","family":"Truelove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0534-5310","authenticated-orcid":false,"given":"E.","family":"Utazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wesolowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.11.020_b0005","unstructured":"World Health Organization. Global vaccine action plan 2011\u20132020; 2013. https:\/\/www.who.int\/immunization\/global_vaccine_action_plan\/GVAP_doc_2011_2020\/en\/ [accessed July 2, 2019]."},{"key":"10.1016\/j.vaccine.2019.11.020_b0010","first-page":"205","article-title":"Measles vaccines: WHO position paper","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.11.020_b0015","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(19)30226-0","article-title":"Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000\u20132016: a spatial and temporal modelling study","volume":"393","author":"Mosser","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.11.020_b0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1126\/science.aau6299","article-title":"Measles and the canonical path to elimination","volume":"364","author":"Graham","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.11.020_b0025","first-page":"301","article-title":"Rubella vaccines: WHO position paper","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.11.020_b0030","unstructured":"Gavi the Vaccine Alliance. Apply for vaccine support; 2019. https:\/\/www.gavi.org\/support\/process\/apply\/vaccine\/#mr [accessed July 2, 2019]."},{"key":"10.1016\/j.vaccine.2019.11.020_b0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/infdis\/jiy137","article-title":"Benefits and challenges in using seroprevalence data to inform models for measles and rubella elimination","volume":"218","author":"Winter","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.020_b0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1756-0500-3-75","article-title":"A review of data needed to parameterize a dynamic model of measles in developing countries","volume":"3","author":"Szusz","year":"2010","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vaccine.2019.11.020_b0045","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(12)60522-4","article-title":"Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data","volume":"379","author":"Simons","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.11.020_b0050","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.vaccine.2018.12.010","article-title":"The value of tailoring vial sizes to populations and locations","volume":"37","author":"Wedlock","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1590\/S1020-49892004001200013","article-title":"Assessing and monitoring vaccination coverage levels: lessons from the Americas","volume":"16","author":"Dietz","year":"2004","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2019.11.020_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001404","article-title":"Measuring coverage in MNCH: Design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys","volume":"10","author":"Cutts","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.11.020_b0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12963-016-0106-0","article-title":"Dynamic denominators: the impact of seasonally varying population numbers on disease incidence estimates","volume":"14","author":"Zu Erbach-Schoenberg","year":"2016","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.vaccine.2019.11.020_b0070","article-title":"A spatial regression model for the disaggregation of areal unit based data to high-resolution grids with application to vaccination coverage mapping","author":"Utazi","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.vaccine.2019.11.020_b0075","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.vaccine.2018.02.020","article-title":"High resolution age-structured mapping of childhood vaccination coverage in low and middle income countries","volume":"36","author":"Utazi","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0080","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.aaa3438","article-title":"Reduced vaccination and the risk of measles and other childhood infections post-Ebola","volume":"347","author":"Takahashi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.11.020_b0085","doi-asserted-by":"crossref","first-page":"15585","DOI":"10.1038\/ncomms15585","article-title":"The geography of measles vaccination in the African Great Lakes region","volume":"8","author":"Takahashi","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2019.11.020_b0090","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1186\/s12889-017-4961-9","article-title":"Spatial clustering of measles vaccination coverage among children in sub-Saharan Africa","volume":"17","author":"Brownwright","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.11.020_b0095","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/j.vaccine.2016.06.053","article-title":"Monitoring vaccination coverage: defining the role of surveys","volume":"34","author":"Cutts","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0100","doi-asserted-by":"crossref","first-page":"170004","DOI":"10.1038\/sdata.2017.4","article-title":"WorldPop, open data for spatial demography","volume":"4","author":"Tatem","year":"2017","journal-title":"Sci Data"},{"key":"10.1016\/j.vaccine.2019.11.020_b0105","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1017\/S0950268814001988","article-title":"Transport networks and inequities in vaccination: remoteness shapes measles vaccine coverage and prospects for elimination across Africa","volume":"143","author":"Metcalf","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.020_b0110","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2471\/BLT.15.162172","article-title":"Inequalities in full immunization coverage: trends in low- and middle-income countries","volume":"94","author":"Restrepo-M\u00e9ndez","year":"2016","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.11.020_b0115","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1016\/j.vaccine.2018.07.051","article-title":"Socioeconomic inequalities and measles immunization coverage in Ecuador: a spatial analysis","volume":"36","author":"Rivadeneira","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0120","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1017\/S0950268810002232","article-title":"Maintaining high rates of measles immunization in Africa","volume":"139","author":"Lessler","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.020_b0125","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1017\/S0950268812000131","article-title":"Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination","volume":"140","author":"Metcalf","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.020_b0130","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1093\/infdis\/jir102","article-title":"Field effectiveness of live attenuated measles-containing vaccines: a review of published literature","volume":"204","author":"Uzicanin","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.020_b0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12080-014-0250-8","article-title":"The effects of maternal immunity and age structure on population immunity to measles","volume":"8","author":"Mckee","year":"2015","journal-title":"Theor Ecol"},{"key":"10.1016\/j.vaccine.2019.11.020_b0140","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.15585\/mmwr.mm6642a6","article-title":"Progress toward regional measles elimination\u2014worldwide, 2000\u20132016","volume":"66","author":"Dabbagh","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2019.11.020_b0145","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/tmi.12737","article-title":"Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries","volume":"21","author":"Cutts","year":"2016","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2019.11.020_b0150","doi-asserted-by":"crossref","first-page":"ofz030","DOI":"10.1093\/ofid\/ofz030","article-title":"Sero-prevalence surveillance to predict vaccine-preventable disease outbreaks; A lesson from the 2014 measles epidemic in northern Vietnam","volume":"6","author":"Choisy","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.020_b0155","unstructured":"Columbia University. PHIA Project \u2013 Zambia; 2019. https:\/\/phia.icap.columbia.edu\/countries\/zambia\/ [accessed July 8, 2019]."},{"key":"10.1016\/j.vaccine.2019.11.020_b0160","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/aje\/kwy114","article-title":"Revealing measles outbreak risk with a nested immunoglobulin G serosurvey in Madagascar","volume":"187","author":"Winter","year":"2018","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.11.020_b0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1017\/S0950268809990173","article-title":"Episodic outbreaks bias estimates of age-specific force of infection: a corrected method using measles as an example","volume":"138","author":"Ferrari","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.020_b0170","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/377695","article-title":"Assessment of the status of measles elimination from reported outbreaks: United States, 1997\u20131999","volume":"189","author":"Gay","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.020_b0175","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S0022172400062859","article-title":"The estimation of age-related rates of infection from case notifications and serological data","volume":"95","author":"Grenfell","year":"1985","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2019.11.020_b0180","first-page":"330","article-title":"Catalytic model of infection for measles","volume":"23","author":"Griffiths","year":"1974","journal-title":"J R Stat Soc Ser C-Appl Stat"},{"key":"10.1016\/j.vaccine.2019.11.020_b0185","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2807\/1560-7917.ES.2018.23.25.1700796","article-title":"Resurgence risk for measles, mumps and rubella in France in 2018 and 2020","volume":"23","author":"Beraud","year":"2018","journal-title":"EUROSURVEILLANCE"},{"key":"10.1016\/j.vaccine.2019.11.020_b0190","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1073\/pnas.1818433116","article-title":"Decreasing measles burden by optimizing campaign timing","volume":"116","author":"Thakkar","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.11.020_b0195","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1473-3099(17)30421-8","article-title":"Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis","volume":"17","author":"Trentini","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.020_b0200","doi-asserted-by":"crossref","first-page":"e1002255","DOI":"10.1371\/journal.pmed.1002255","article-title":"Demographic transition and the dynamics of measles in six provinces in China: a modeling study","volume":"14","author":"Li","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.11.020_b0205","doi-asserted-by":"crossref","first-page":"20120141","DOI":"10.1098\/rstb.2012.0141","article-title":"Think globally, act locally: the role of local demographics and vaccination coverage in the dynamic response of measles infection to control","volume":"368","author":"Ferrari","year":"2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2019.11.020_b0210","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/S1473-3099(17)30307-9","article-title":"The basic reproduction number (R0) of measles: a systematic review","volume":"17","author":"Guerra","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.020_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2501.171901","article-title":"Complexity of the basic reproduction number (R0)","volume":"25","author":"Delamater","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.020_b0220","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/381592","article-title":"The theory of measles elimination: implications for the design of elimination strategies","volume":"189","author":"Gay","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.020_b0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/oxfordjournals.epirev.a036121","article-title":"Herd immunity: history, theory, practice","volume":"15","author":"Fine","year":"1993","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2019.11.020_b0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1017\/S0950268800065614","article-title":"Measles in developing countries. Part I. Epidemiological parameters and patterns","volume":"100","author":"McLean","year":"1988","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.020_b0235","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.vaccine.2018.12.012","article-title":"Characterizing the impact of spatial clustering of susceptibility for measles elimination","volume":"37","author":"Truelove","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0240","doi-asserted-by":"crossref","first-page":"e67639","DOI":"10.1371\/journal.pone.0067639","article-title":"Balancing evidence and uncertainty when considering rubella vaccine introduction","volume":"8","author":"Lessler","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.11.020_b0245","doi-asserted-by":"crossref","first-page":"e1006806","DOI":"10.1371\/journal.pcbi.1006806","article-title":"Characteristics of measles epidemics in China (1951\u20132004) and implications for elimination: a case study of three key locations","volume":"15","author":"Yang","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2019.11.020_b0250","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1017\/S0950268810002165","article-title":"The epidemiology of rubella in Mexico: seasonality, stochasticity and regional variation","volume":"139","author":"Metcalf","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.020_b0255","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0169-5347(97)01174-9","article-title":"(Meta)population dynamics of infectious diseases","volume":"12","author":"Grenfell","year":"1997","journal-title":"Trends Ecol Evol"},{"key":"10.1016\/j.vaccine.2019.11.020_b0260","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature06509","article-title":"The dynamics of measles in sub-Saharan Africa","volume":"451","author":"Ferrari","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.11.020_b0265","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1017\/S0950268809991385","article-title":"Measles hotspots and epidemiological connectivity","volume":"138","author":"Bharti","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.020_b0270","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.13.30177","article-title":"A unique measles B3 cluster in the United Kingdom and the Netherlands linked to air travel and transit at a large international airport, February to April 2014","volume":"21","author":"Nic Lochlainn","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2019.11.020_b0275","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/infdis\/jiy701","article-title":"International importations of measles virus into the United States during the postelimination era, 2001\u20132016","volume":"219","author":"Lee","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.020_b0280","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1126\/science.1210554","article-title":"Explaining seasonal fluctuations of measles in Niger using nighttime lights imagery","volume":"334","author":"Bharti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.11.020_b0285","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1473-3099(16)00004-9","article-title":"The effect of heterogeneity in uptake of the measles, mumps, and rubella vaccine on the potential for outbreaks of measles: a modelling study","volume":"16","author":"Glasser","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.020_b0290","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12916-019-1413-7","article-title":"Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination","volume":"17","author":"Funk","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2019.11.020_b0295","doi-asserted-by":"crossref","first-page":"11114","DOI":"10.1073\/pnas.1423542112","article-title":"Quantifying seasonal population fluxes driving rubella transmission dynamics using mobile phone data","volume":"112","author":"Wesolowski","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.11.020_b0300","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/s41467-017-02064-4","article-title":"Multinational patterns of seasonal asymmetry in human movement influence infectious disease dynamics","volume":"8","author":"Wesolowski","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2019.11.020_b0305","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1017\/S0950268817003077","article-title":"Correlation between measles vaccine doses: implications for the maintenance of elimination","volume":"146","author":"McKee","year":"2018","journal-title":"Epidemiol Infect"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.11.020_b0310","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1093\/infdis\/jir131","article-title":"The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda","volume":"204","author":"Bishai","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.020_b0315","doi-asserted-by":"crossref","first-page":"e0199786","DOI":"10.1371\/journal.pone.0199786","article-title":"Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016","volume":"13","author":"Subaiya","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.11.020_b0320","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.vaccine.2017.10.080","article-title":"Impact of measles supplementary immunization activities on reaching children missed by routine programs","volume":"36","author":"Portnoy","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0325","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2471\/BLT.07.048579","article-title":"Epidemiological impact of a nationwide measles immunization campaign in Viet Nam: a critical review","volume":"86","author":"Murakami","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.11.020_b0330","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1586\/14760584.2013.814847","article-title":"Measles elimination: progress, challenges and implications for rubella control","volume":"12","author":"Cutts","year":"2013","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.11.020_b0335","first-page":"15","article-title":"Measles case-based surveillance and outbreak response in Nigeria; an update for clinicians and public health professionals","volume":"12","author":"Isere","year":"2014","journal-title":"Ann Ib Postgrad Med"},{"key":"10.1016\/j.vaccine.2019.11.020_b0340","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.vaccine.2017.02.008","article-title":"Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?","volume":"35","author":"Prada","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0345","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/s41467-019-09611-1","article-title":"Mapping vaccination coverage to explore the effects of delivery mechanisms and inform vaccination strategies","volume":"10","author":"Utazi","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2019.11.020_b0350","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1073\/pnas.1715305115","article-title":"Spatially disaggregated population estimates in the absence of national population and housing census data","volume":"115","author":"Wardrop","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.11.020_b0355","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.vaccine.2008.07.005","article-title":"Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys","volume":"26","author":"Nigatu","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0360","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1017\/S0950268808000848","article-title":"Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models","volume":"137","author":"Ohuma","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.020_b0365","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0264-410X(02)00480-2","article-title":"Difficulties in measles elimination: prevalence of measles antibodies before and after mass vaccination campaign in Laos","volume":"21","author":"Kuroiwa","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0370","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S0950268817002527","article-title":"Rubella vaccination in India: identifying broad consequences of vaccine introduction and key knowledge gaps","volume":"146","author":"Winter","year":"2018","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.020_b0375","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyz058","article-title":"Evaluating vaccination policies to accelerate measles elimination in China: a meta-population modelling study","author":"Hao","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.11.020_b0380","doi-asserted-by":"crossref","first-page":"e0194931","DOI":"10.1371\/journal.pone.0194931","article-title":"Evaluation of nationwide supplementary immunization in Lao People\u2019s Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine","volume":"13","author":"Hachiya","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.11.020_b0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001544","article-title":"Measles outbreak response immunization is context-specific: insight from the recent experience of medicines Sans Frontiers","volume":"10","author":"Minetti","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.11.020_b0390","doi-asserted-by":"crossref","first-page":"e0205339","DOI":"10.1371\/journal.pone.0205339","article-title":"Monitoring the age-specificity of measles transmissions during 2009\u20132016 in Southern China","volume":"13","author":"Chong","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.11.020_b0395","first-page":"2541","article-title":"Seasonal infectious disease epidemiology","volume":"273","author":"Grassly","year":"2006","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.vaccine.2019.11.020_b0400","doi-asserted-by":"crossref","first-page":"180256","DOI":"10.1038\/sdata.2018.256","article-title":"Fluctuations in anthropogenic nighttime lights from satellite imagery for five cities in Niger and Nigeria","volume":"5","author":"Bharti","year":"2018","journal-title":"Sci Data"},{"key":"10.1016\/j.vaccine.2019.11.020_b0405","doi-asserted-by":"crossref","first-page":"34541","DOI":"10.1038\/srep34541","article-title":"Measuring populations to improve vaccination coverage","volume":"5","author":"Bharti","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.11.020_b0410","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pt.2016.10.006","article-title":"Seasonal population movements and the surveillance and control of infectious diseases","volume":"33","author":"Buckee","year":"2017","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2019.11.020_b0415","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.vaccine.2014.11.050","article-title":"Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy","volume":"33","author":"Verguet","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0420","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1016\/j.vaccine.2019.08.050","article-title":"Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: a cost-effectiveness analysis","volume":"37","author":"Zimmermann","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0425","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1186\/s12889-018-5628-x","article-title":"Sub-national variation in measles vaccine coverage and outbreak risk: a case study from a 2010 outbreak in Malawi","volume":"18","author":"Kundrick","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.11.020_b0430","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/aje\/kwt236","article-title":"Reaching hard-to-reach individuals: nonselective versus targeted outbreak response vaccination for measles","volume":"179","author":"Minetti","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.11.020_b0435","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1471-2458-14-193","article-title":"Local discrepancies in measles vaccination opportunities: results of population-based surveys in Sub-Saharan Africa","volume":"14","author":"Grout","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.11.020_b0440","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1017\/S0950268818001449","article-title":"Measles outbreak risk in Pakistan: exploring the potential of combining vaccination coverage and incidence data with novel data-streams to strengthen control","volume":"146","author":"Wesolowski","year":"2018","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.020_b0445","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4269\/ajtmh.17-0218","article-title":"Challenges and opportunities in disease forecasting in outbreak settings: a case study of measles in Lola Prefecture, Guinea","volume":"98","author":"Graham","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.11.020_b0450","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0575","article-title":"Measles outbreak response decision-making under uncertainty: a retrospective analysis","volume":"15","author":"Fonnesbeck","year":"2018","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.vaccine.2019.11.020_b0455","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1136\/bmj.319.7223.1462","article-title":"Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review","volume":"319","author":"Panagiotopoulos","year":"1999","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.11.020_b0460","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1086\/368053","article-title":"Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience","volume":"187","author":"Morice","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.020_b0465","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.inf.0000260000.84792.9e","article-title":"Estimating the burden of congenital rubella syndrome in Costa Rica, 1996\u20132001","volume":"26","author":"Jimenez","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.11.020_b0470","series-title":"Mathematical and statistical estimation approaches in epidemiology","first-page":"325","article-title":"Spatial and temporal dynamics of Rubella in Peru, 1997\u20132006: geographic patterns, age at infection and estimation of transmissibility","author":"Rios-Doria","year":"2009"},{"key":"10.1016\/j.vaccine.2019.11.020_b0475","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1098\/rsif.2010.0320","article-title":"Rubella metapopulation dynamics and importance of spatial coupling to the risk of congenital rubella syndrome in Peru","volume":"8","author":"Metcalf","year":"2011","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.vaccine.2019.11.020_b0480","doi-asserted-by":"crossref","first-page":"20151101","DOI":"10.1098\/rsif.2015.1101","article-title":"Introduction of rubella-containing-vaccine to Madagascar: implications for roll-out and local elimination","volume":"13","author":"Wesolowski","year":"2016","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.vaccine.2019.11.020_b0485","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.vaccine.2019.04.019","article-title":"Trends and spatial distribution of MMR vaccine coverage in Brazil during 2007\u20132017","volume":"37","author":"Pacheco","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0490","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/erv.12.47","article-title":"Measurement of vaccine-derived immunity: how do we use all the data?","volume":"11","author":"Lessler","year":"2012","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.11.020_b0495","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.vaccine.2019.03.007","article-title":"Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: A modeling application in Kenya","volume":"37","author":"Lee","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0500","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1016\/j.vaccine.2019.08.049","article-title":"The cost saving opportunity of introducing a card review into measles-containing vaccination campaigns","volume":"37","author":"Hagedorn","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0505","doi-asserted-by":"crossref","first-page":"e0201700","DOI":"10.1371\/journal.pone.0201700","article-title":"Modelling spatio-temporal patterns of disease for spatially misaligned data: an application on measles incidence data in Namibia from 2005\u20132014","volume":"13","author":"Ntirampeba","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.11.020_b0510","unstructured":"Vaccination coverage cluster surveys: reference manual. Geneva: World Health Organization; 2018 [WHO\/ IVB\/18.09, License: CC BY-NC-SA 3.0 IGO]."},{"issue":"41","key":"10.1016\/j.vaccine.2019.11.020_b0515","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1016\/j.vaccine.2019.08.050","article-title":"Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: a cost-effectiveness analysis","volume":"37","author":"Zimmerman","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.020_b0520","article-title":"Measles outbreak in 2018\u20132019, Madagascar: epidemiology and public health implications","author":"Nimpa","year":"2019","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.vaccine.2019.11.020_b0525","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/ije\/19.3.703","article-title":"Measles immunization strategies for countries with high transmission rates: interim guidelines predicted using a mathematical model","volume":"19","author":"Nokes","year":"1990","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.11.020_b0530","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0950268810001329","article-title":"Modelling the first dose of measles vaccination: the role of maternal immunity, demographic factors, and delivery systems","volume":"139","author":"Metcalf","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.11.020_b0535","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.epidem.2014.08.004","article-title":"Seven challenges in modeling vaccine preventable diseases","volume":"10","author":"Metcalf","year":"2015","journal-title":"Epidemics"},{"key":"10.1016\/j.vaccine.2019.11.020_b0540","doi-asserted-by":"crossref","first-page":"923","DOI":"10.12688\/gatesopenres.12916.1","article-title":"A systematic review of the agreement of recall, home-based records, facility records, BCG scar, and serology for ascertaining vaccination status in low and middle-income countries","volume":"3","author":"Dansereau","year":"2019","journal-title":"Gates Open Research"},{"key":"10.1016\/j.vaccine.2019.11.020_b0545","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/inthealth\/ihu057","article-title":"Mapping the denominator: spatial demography in the measurement of progress","volume":"6","author":"Tatem","year":"2014","journal-title":"Int Health"},{"key":"10.1016\/j.vaccine.2019.11.020_b0550","first-page":"453","article-title":"Electronic immunization registries in Latin America: progress and lessons learned","volume":"35","author":"Danovaro-Holliday","year":"2014","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2019.11.020_b0555","doi-asserted-by":"crossref","first-page":"130","DOI":"10.29245\/2578-3009\/2018\/si.1119","article-title":"Performance of national measles case-based surveillance systems in the WHO African region. 2012\u20132016","volume":"Suppl","author":"Masresha","year":"2018","journal-title":"J Immunol Sci"},{"key":"10.1016\/j.vaccine.2019.11.020_b0560","doi-asserted-by":"crossref","first-page":"e1002673","DOI":"10.1371\/journal.pcbi.1002673","article-title":"Inferring the structure of social contacts from demographic data in the analysis of infectious diseases spread","volume":"8","author":"Fumanelli","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2019.11.020_b0565","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2015.0073","article-title":"Fine resolution mapping of population age-structures for health and development applications","volume":"12","author":"Alegana","year":"2015","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.vaccine.2019.11.020_b0570","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.epidem.2014.08.008","article-title":"Six challenges in modelling for public health policy","volume":"10","author":"Metcalf","year":"2015","journal-title":"Epidemics"},{"key":"10.1016\/j.vaccine.2019.11.020_bib571","unstructured":"World Health Organization, Measles Programmatic Risk Assessment Tool; 2018. [accessed 20 November 2019]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:15:36Z","timestamp":1777536936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19315439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19315439"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}